Intra-tumor heterogeneity from a cancer stem cell perspective.

Prasetyanti PR, Medema JP. · 2017

Read Intra-tumor heterogeneity from a cancer stem cell perspective. by Prasetyanti PR, Medema JP. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5314464.txt.

Description

Pramudita R. Prasetyanti and Jan Paul Medema reviewed tumor diversity in Molecular Cancer in 2017. No two cells in a tumor are quite alike. They differ in growth rate, surface marks, gene flaws, and response to drugs. That mix helps tumors grow back after treatment. Cancer stem cells, rare cells that can renew the tumor, are one source of the mix.

The review adds a twist: the stem-like state is not fixed. A tumor cell can gain stem traits through gene changes or through signals from the tissue around it. So the pool of stem-like cells shifts over time. The authors sort the forces that build this shifting mix, from gene and mark changes to cues from nearby support cells. They close with what this means for therapy: drugs must face a moving target, not a fixed cell type.

Catalog record

CREATORPrasetyanti PR, Medema JP.
YEAR2017
COLLECTIONPAPERS
FORMATTXT
FILE SIZE50 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5314464

Browse the full library · About the Tower of Babel